SIGLEC15 and glioblastoma: We found that except LAG3, the levels of CD274, CTLA4, HAVCR2, PDCD1, PDCD1LG2, TIGIT and SIGLEC15 were all significantly increased in CCL2-high GBM group (Fig. 6A).